Search

Your search keyword '"Di Marco, Vito"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Di Marco, Vito" Remove constraint Author: "Di Marco, Vito" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
192 results on '"Di Marco, Vito"'

Search Results

1. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

2. Real-world experience with long-term albumin in patients with cirrhosis and ascites☆

3. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

5. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

6. Factors Associated with Primary Liver Cancer Survival in a Southern Italian Setting in a Changing Epidemiological Scenario

7. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies

10. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

12. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

14. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

15. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

16. Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders

17. Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development

19. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study

20. AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD

21. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies

22. Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals

23. A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease

24. Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant

26. A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

28. First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials

29. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel

30. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

31. Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach

32. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

33. First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials

34. Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

36. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

37. Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

38. Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity.

39. Development of a Severity Score System for Thalassemia Syndromes

40. First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials.

41. Liver stiffness quantification in biopsyproven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography.

42. NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients

43. Real life experiences in HCV management in 2018

44. Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia.

45. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

46. The necessary encounter between culture and digital literacy

47. Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study

48. The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity

49. Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Catalog

Books, media, physical & digital resources